HCG 125iu/0 — Class II drug recall D-740-2013
Ongoing recall by Lowlite Investments, Inc. D/B/A Olympia Pharmacy, reported 2013-07-17, distributed nationwide. Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control process
| Recall number | D-740-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lowlite Investments, Inc. D/B/A Olympia Pharmacy, Orlando, FL, United States |
| Recall initiated | 2013-05-29 |
| Classified | 2013-07-11 |
| Reported by FDA | 2013-07-17 |
| Distributed | Nationwide (US) |
| Quantity | 3 |
| Reason classes | sterility |
| Lot numbers | 10000, 3500IU, A3504, C3105, C3611 |
| Expiration dates | 2013-08-31, 2013-09-05, 2013-09-06 |
Product
HCG 125iu/0.25ml (550iu/ml), 3500iu and 10,000iu, compounded by Olympia Pharmacy, Orlando, FL
Reason for recall
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-740-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.